https://mtorsignals.com/index.....php/microrna-deregul
Most obstructions had been considered complex. The success prices had been saturated in both groups (p0.05). There were no unfavorable activities linked to the utilization of mitomycin C (p0.05). Conclusions Although mitomycin C has no negative effects when placed on the opening associated with the nasolacrimal duct, its use after lacrimal probing for the treatment of congenital nasolacrimal duct obstruction will not improve chance of success.Backg
Like
Comment
Share
